Lam Research (LRCX) IV increasing as shares rally into Q1
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Lam Research (LRCX) PT Raised to $270 at BofA/Merrill Lynch Following 1Q Release
October 18, 2017 9:46 AM EDTBofA/Merrill Lynch raised its price target on Lam Research (NASDAQ: LRCX) to $270.00 (from $230.00) while maintaining a Buy rating following the company's 1Q. LRCX reported revenues/EPS of $2.48B/$3.46, ahead of the Street at $2.47B/$3.28.
The Dec Q rev/EPS guidance of... More
Lam Research (LRCX) PT Raised to $200 at Susquehanna Following 3Q Report
October 18, 2017 7:35 AM EDTSusquehanna raised its price target on Lam Research (NASDAQ: LRCX) to $200.00 (from $145.00) while maintaining a Neutral rating following the company's 1Q earnings release. Lam had another beat and raise, reflecting the strong spend in the Memory segment.
Total WFE spend is expected... More
